9-35813524-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 4P and 4B. PP3_StrongBS2
The NM_032593.3(HINT2):c.248C>T(p.Pro83Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000321 in 1,614,102 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00022 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00033 ( 2 hom. )
Consequence
HINT2
NM_032593.3 missense
NM_032593.3 missense
Scores
16
2
1
Clinical Significance
Conservation
PhyloP100: 8.19
Genes affected
HINT2 (HGNC:18344): (histidine triad nucleotide binding protein 2) Histidine triad proteins, such as HINT2, are nucleotide hydrolases and transferases that act on the alpha-phosphate of ribonucleotides (Brenner, 2002 [PubMed 12119013]).[supplied by OMIM, Mar 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.979
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HINT2 | NM_032593.3 | c.248C>T | p.Pro83Leu | missense_variant | 3/5 | ENST00000259667.6 | NP_115982.1 | |
HINT2 | XM_024447702.2 | c.254C>T | p.Pro85Leu | missense_variant | 3/5 | XP_024303470.1 | ||
HINT2 | XM_024447703.1 | c.254C>T | p.Pro85Leu | missense_variant | 3/5 | XP_024303471.1 | ||
HINT2 | XM_024447704.2 | c.248C>T | p.Pro83Leu | missense_variant | 3/5 | XP_024303472.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HINT2 | ENST00000259667.6 | c.248C>T | p.Pro83Leu | missense_variant | 3/5 | 1 | NM_032593.3 | ENSP00000259667.5 | ||
ENSG00000285645 | ENST00000650284.1 | n.*722C>T | non_coding_transcript_exon_variant | 8/10 | ENSP00000498023.1 | |||||
ENSG00000285645 | ENST00000650284.1 | n.*722C>T | 3_prime_UTR_variant | 8/10 | ENSP00000498023.1 |
Frequencies
GnomAD3 genomes AF: 0.000223 AC: 34AN: 152220Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
34
AN:
152220
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000263 AC: 66AN: 251428Hom.: 0 AF XY: 0.000250 AC XY: 34AN XY: 135888
GnomAD3 exomes
AF:
AC:
66
AN:
251428
Hom.:
AF XY:
AC XY:
34
AN XY:
135888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000331 AC: 484AN: 1461882Hom.: 2 Cov.: 32 AF XY: 0.000323 AC XY: 235AN XY: 727242
GnomAD4 exome
AF:
AC:
484
AN:
1461882
Hom.:
Cov.:
32
AF XY:
AC XY:
235
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000223 AC: 34AN: 152220Hom.: 0 Cov.: 33 AF XY: 0.000188 AC XY: 14AN XY: 74374
GnomAD4 genome
AF:
AC:
34
AN:
152220
Hom.:
Cov.:
33
AF XY:
AC XY:
14
AN XY:
74374
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
3
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
6
ExAC
AF:
AC:
24
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2024 | The c.248C>T (p.P83L) alteration is located in exon 3 (coding exon 3) of the HINT2 gene. This alteration results from a C to T substitution at nucleotide position 248, causing the proline (P) at amino acid position 83 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Pathogenic
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Pathogenic
D
Polyphen
D
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at